ABBV
Price
$210.50
Change
+$2.57 (+1.24%)
Updated
Aug 29, 04:59 PM (EDT)
Capitalization
367.3B
56 days until earnings call
SCLX
Price
$17.97
Change
-$0.26 (-1.43%)
Updated
Aug 29, 04:15 PM (EDT)
Capitalization
126.8M
Interact to see
Advertisement

ABBV vs SCLX

Header iconABBV vs SCLX Comparison
Open Charts ABBV vs SCLXBanner chart's image
ABBVIE
Price$210.50
Change+$2.57 (+1.24%)
Volume$29.73K
Capitalization367.3B
Scilex Holding
Price$17.97
Change-$0.26 (-1.43%)
Volume$100
Capitalization126.8M
ABBV vs SCLX Comparison Chart in %
Loading...
ABBV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABBV vs. SCLX commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABBV is a StrongBuy and SCLX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (ABBV: $207.92 vs. SCLX: $18.23)
Brand notoriety: ABBV: Notable vs. SCLX: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: ABBV: 82% vs. SCLX: 50%
Market capitalization -- ABBV: $367.3B vs. SCLX: $126.8M
ABBV [@Pharmaceuticals: Major] is valued at $367.3B. SCLX’s [@Pharmaceuticals: Major] market capitalization is $126.8M. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $656.17B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $88.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABBV’s FA Score shows that 2 FA rating(s) are green whileSCLX’s FA Score has 0 green FA rating(s).

  • ABBV’s FA Score: 2 green, 3 red.
  • SCLX’s FA Score: 0 green, 5 red.
According to our system of comparison, ABBV is a better buy in the long-term than SCLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABBV’s TA Score shows that 4 TA indicator(s) are bullish while SCLX’s TA Score has 3 bullish TA indicator(s).

  • ABBV’s TA Score: 4 bullish, 4 bearish.
  • SCLX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ABBV is a better buy in the short-term than SCLX.

Price Growth

ABBV (@Pharmaceuticals: Major) experienced а -0.75% price change this week, while SCLX (@Pharmaceuticals: Major) price change was +6.36% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.84%. For the same industry, the average monthly price growth was +1.29%, and the average quarterly price growth was +11.90%.

Reported Earning Dates

ABBV is expected to report earnings on Oct 24, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.84% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABBV($367B) has a higher market cap than SCLX($127M). SCLX YTD gains are higher at: 22.152 vs. ABBV (20.231). ABBV has higher annual earnings (EBITDA): 14.2B vs. SCLX (-70.91M). ABBV has more cash in the bank: 6.47B vs. SCLX (4.1M). SCLX has less debt than ABBV: SCLX (41.8M) vs ABBV (70.5B). ABBV has higher revenues than SCLX: ABBV (58.3B) vs SCLX (44.2M).
ABBVSCLXABBV / SCLX
Capitalization367B127M288,976%
EBITDA14.2B-70.91M-20,025%
Gain YTD20.23122.15291%
P/E Ratio99.01N/A-
Revenue58.3B44.2M131,900%
Total Cash6.47B4.1M157,770%
Total Debt70.5B41.8M168,660%
FUNDAMENTALS RATINGS
ABBV: Fundamental Ratings
ABBV
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
PROFIT vs RISK RATING
1..100
11
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
24
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABBVSCLX
RSI
ODDS (%)
Bearish Trend 2 days ago
42%
Bearish Trend 2 days ago
38%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
48%
Bearish Trend 2 days ago
47%
Momentum
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
44%
MACD
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
43%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
45%
Bullish Trend 2 days ago
47%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
36%
Advances
ODDS (%)
Bullish Trend 8 days ago
57%
Bullish Trend 12 days ago
71%
Declines
ODDS (%)
Bearish Trend 2 days ago
44%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
38%
Bearish Trend 2 days ago
40%
Aroon
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
25%
View a ticker or compare two or three
Interact to see
Advertisement
ABBV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ROAM27.140.21
+0.77%
Hartford Multifactor Emerging Mkts ETF
GWX39.360.27
+0.69%
SPDR® S&P® International Small Cap ETF
DBAW38.390.06
+0.16%
Xtrackers MSCI All World exUS Hdg Eq ETF
USMV94.03-0.03
-0.03%
iShares MSCI USA Min Vol Factor ETF
REKT18.11-0.07
-0.37%
Direxion Daily Crypto Industry Bear1XETF

SCLX and

Correlation & Price change

A.I.dvisor tells us that SCLX and BIIB have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SCLX and BIIB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCLX
1D Price
Change %
SCLX100%
+1.17%
BIIB - SCLX
20%
Poorly correlated
-2.72%
AMRN - SCLX
20%
Poorly correlated
-0.42%
SNY - SCLX
9%
Poorly correlated
-0.34%
ABBV - SCLX
8%
Poorly correlated
-0.07%
RHHVF - SCLX
8%
Poorly correlated
-1.80%
More